Tazorac and Intervertebral disc protrusion - a phase IV clinical study of FDA data

Summary:

Intervertebral disc protrusion is reported as a side effect among people who take Tazorac (tazarotene), especially for people who are female, 30-39 old, also take Decadron, and have Vitiligo.

The phase IV clinical study analyzes which people have Intervertebral disc protrusion when taking Tazorac. It is created by eHealthMe based on reports of 1,001 people who have side effects when taking Tazorac from the FDA, and is updated regularly.

What is Tazorac?

Tazorac has active ingredients of tazarotene. It is often used in acne. eHealthMe is studying from 1,046 Tazorac users. Check the latest studies of Tazorac.

What is Intervertebral disc protrusion?

Intervertebral disc protrusion (spinal disc protrusion) is found to be associated with 1,531 drugs and 1,306 conditions by eHealthMe. Check the latest studies of Intervertebral disc protrusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,001 people reported to have side effects when taking Tazorac.
Among them, 12 people (1.2%) have Intervertebral disc protrusion.

Could Tazorac cause Intervertebral disc protrusion?

Among these 12 people:

What is the gender of people who have Intervertebral disc protrusion when taking Tazorac? *

female: 100 %
male: 0.0 %

What is the age of people who have Intervertebral disc protrusion when taking Tazorac? *

What are other drugs people take besides Tazorac? *

What are other side effects people have besides Intervertebral disc protrusion? *

Anaemia (lack of blood): 12 people, 100.00%
Biopsy Breast Abnormal: 12 people, 100.00%
Breast Cancer Female: 12 people, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 100.00%
Ovarian Cysts (fluid filled sacs of the ovary): 12 people, 100.00%
Hair Loss: 11 people, 91.67%
Conjunctivitis (pink eye): 11 people, 91.67%
Erythema Of Eyelid (redness of the eyelid): 11 people, 91.67%
Neck Pain: 11 people, 91.67%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 11 people, 91.67%

What are the existing conditions these people have? *

Vitiligo (pigment is lost from areas of the skin): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tazorac and have Intervertebral disc protrusion?

- Check whether Intervertebral disc protrusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazorac:

Tazorac (1,046 reports)

Browse all side effects of Tazorac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,531 drugs)

Browse all the conditions that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,306 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tazarotene (the active ingredients of Tazorac) and Tazorac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.